hCG-Regulated CXCL10 Suppression via H3K27me3 in Decidua
2026-07-20
This study reveals that human chorionic gonadotropin (hCG) suppresses the chemokine CXCL10 in human decidual stromal cells through the induction of H3K27me3 histone methylation, mediated by EZH2 of the PRC2 complex. These findings highlight a crucial epigenetic mechanism for immune cell recruitment at the maternal-fetal interface and offer new perspectives for epigenetic regulation research.
Advances in Antifungal Therapy: Oteseconazole and Candida au
2026-07-20
This systematic review highlights the urgent need for new antifungal agents to address multidrug-resistant Candida auris infections and evaluates the in vitro and in vivo activity of agents in the current antifungal pipeline. Tetrazole CYP51 inhibitors such as Oteseconazole (VT-1161) emerge as promising candidates, demonstrating improved selectivity, potency, and potential to overcome resistance mechanisms.
Molidustat (BAY85-3934): Optimizing HIF Stabilization for Re
2026-07-19
Molidustat (BAY85-3934) offers precise, reliable hypoxia-inducible factor stabilization for robust erythropoietin research and chronic kidney disease anemia models. This guide details actionable workflows, key reference insights, and troubleshooting strategies to maximize the translational power of APExBIO’s Molidustat.
Carbenoxolone Disodium: Technical Use Guide for 11β-HSD Inhi
2026-07-18
Carbenoxolone disodium is a high-purity 11β-hydroxysteroid dehydrogenase inhibitor designed for mechanistic studies of glucocorticoid regulation and gap junction communication in tissue- and cell-based research. It is not intended for in vivo efficacy studies or for experiments demanding rigorous off-target specificity.
HMGCS2 Downregulation Drives AECII Lipid Alterations in Pulm
2026-07-17
Yang et al. (2024) reveal that loss of HMGCS2 in alveolar epithelial cells disrupts lipid metabolism, causing lysophosphatidylcholine accumulation that activates fibroblasts and accelerates pulmonary fibrosis. This mechanistic insight clarifies the cellular origin of pathogenic lipids and suggests new intervention points for fibrosis research.
Optimizing Cancer Assays with MK-1775 (Wee1 Kinase Inhibitor
2026-07-17
This article explores real-world laboratory scenarios in which MK-1775 (Wee1 kinase inhibitor, SKU A5755) enables precise, reproducible cell cycle checkpoint abrogation and sensitization of p53-deficient tumor cells. By grounding best practices in published evidence and practical parameters, the guide empowers researchers to leverage reliable performance data and validated protocols for advanced in vitro cancer assays.
Cy3 NHS ester (non-sulfonated): Technical Guide for Biomolec
2026-07-16
Cy3 NHS ester (non-sulfonated) enables precise fluorescent labeling of proteins, peptides, and oligonucleotides for sensitive detection in imaging workflows that tolerate organic solvents. It is not suitable for labeling delicate proteins or workflows requiring aqueous-only conditions. Researchers benefit from its high extinction coefficient and orange emission but must address solubility, handling, and storage constraints for reproducible results.
Mc-Val-Cit-PABC-PNP: Technical Guide for ADC Synthesis Workf
2026-07-16
Mc-Val-Cit-PABC-PNP is a cathepsin B-cleavable ADC peptide linker designed for targeted cytotoxic payload release in antibody-drug conjugate (ADC) research. It should be used exclusively in organic solvent-based workflows, avoiding aqueous, diagnostic, or clinical applications to preserve compound integrity and efficacy.
HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit Plus: Techni
2026-07-15
The HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit Plus enables high-yield synthesis of fluorescent RNA probes for use in research workflows such as in situ hybridization and Northern blotting. It addresses the need for reproducible, sensitive RNA probe labeling when direct Cy3 incorporation is needed. Use is strictly limited to research applications and not suitable for clinical, diagnostic, or therapeutic settings.
D-Luciferin (Potassium Salt): Enabling Precision Tumor Imagi
2026-07-15
Explore how D-Luciferin (potassium salt) empowers in vivo bioluminescence imaging for precision brain tumor research. This article uniquely bridges substrate chemistry, BBB challenges, and nanoparticle delivery—advancing practical assay decisions in neuro-oncology.
Crizotinib Hydrochloride in Gastric Cancer Assembloids: A Tr
2026-07-14
This thought-leadership article explores the mechanistic underpinnings and strategic integration of Crizotinib hydrochloride, a potent ALK kinase inhibitor, within patient-derived gastric cancer assembloid models. Drawing on recent advances in organoid and stromal cell co-culture systems, we contextualize how this compound enables deeper interrogation of oncogenic kinase pathways, informs resistance mechanisms, and accelerates precision oncology workflows. The article distills experimental validation, protocol parameters, and translational guidance for researchers, with a forward-looking perspective on model-driven drug discovery.
AT-406 (SM-406): Advanced Insights into Targeting IAPs in Ca
2026-07-14
Discover the latest mechanistic advances in apoptosis pathway targeting with AT-406 (SM-406), a potent orally bioavailable IAP antagonist. This article uniquely links structural biology breakthroughs to assay optimization in cancer research.
Heptamethine Cyanine Dye Targets Progesterone Receptor in HR
2026-07-13
This study introduces a novel tumor-targeted heptamethine cyanine dye, CA800-PR, that selectively suppresses progesterone receptor activity and induces Golgi fragmentation in hormone receptor-positive breast cancer. These findings suggest an innovative therapeutic approach beyond traditional hormone therapies, with implications for both targeted treatment and mechanistic cell biology.
Dinaciclib (SCH727965): Multi-CDK Inhibitor in Cancer Resear
2026-07-13
Dinaciclib (SCH727965) is a potent, selective inhibitor of CDK1, CDK2, CDK5, and CDK9, enabling precise control of cell cycle arrest and apoptosis in cancer research. Its high solubility in DMSO and efficacy in both in vitro and in vivo models make it a valuable tool for dissecting cyclin-dependent kinase signaling pathways.
Hypoxia and Immunometabolism in Tumor Microenvironments
2026-07-12
This review explores how hypoxia-driven metabolic reprogramming and immune metabolism shape the tumor microenvironment (TME), promoting immunosuppression and supporting malignant progression. The paper provides a detailed mechanistic framework for understanding metabolic adaptation in cancer and highlights the prospects and limitations of targeting TME metabolism in future therapies.
470 records 12/32 page Previous Next First page 上5页 1112131415 下5页 Last page